SITAGLIPTINE/METFORMINE TEVA 50 mg/1000 mg, comprimé pelliculé — plaquette(s) PVC PVDC aluminium de 60 comprimé(s)

Conditionnement de médicament · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930244425
  • CIP7 3024442
  • CIS 60437225

Ce que publie la source

Titulaire
TEVA SANTE
Substances actives
SITAGLIPTINE, CHLORHYDRATE DE METFORMINE, CHLORHYDRATE DE SITAGLIPTINE MONOHYDRATÉ
Forme
comprimé pelliculé
Conditionnement
plaquette(s) PVC PVDC aluminium de 60 comprimé(s)
Voies d’administration
orale
Statut administratif
authorised
Régime de délivrance
liste I
Statut de commercialisation
Déclaration de commercialisation
Date d’autorisation
2021-12-30
Prescription
Sur ordonnance ou à délivrance restreinte

Noms permettant de trouver cette fiche

Données complètes de la source
fr:ansm:packages:3400930244425
{
  "cis": "60437225",
  "cip7": "3024442",
  "form": "comprimé pelliculé",
  "name": "SITAGLIPTINE/METFORMINE TEVA 50 mg/1000 mg, comprimé pelliculé — plaquette(s) PVC PVDC aluminium de 60 comprimé(s)",
  "cip13": "3400930244425",
  "holder": "TEVA SANTE",
  "routes": [
    "orale"
  ],
  "holders": [
    "TEVA SANTE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "9.64",
  "authorisedOn": "2021-12-30",
  "compositions": [
    {
      "name": "SITAGLIPTINE",
      "nature": "FT",
      "strength": "50 mg",
      "linkageNumber": "1",
      "substanceCode": "20740",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "CHLORHYDRATE DE METFORMINE",
      "nature": "SA",
      "strength": "1000 mg",
      "linkageNumber": "2",
      "substanceCode": "24321",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "CHLORHYDRATE DE SITAGLIPTINE MONOHYDRATÉ",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "85939",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "8.62",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "SITAGLIPTINE/METFORMINE TEVA 50 mg/1000 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) PVC PVDC aluminium de 60 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "30 %"
  ],
  "marketingDeclaredOn": "2023-04-11",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "SITAGLIPTINE",
    "CHLORHYDRATE DE METFORMINE",
    "CHLORHYDRATE DE SITAGLIPTINE MONOHYDRATÉ"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Lisez cette fiche depuis votre propre logiciel

La même fiche, avec tous ses champs et sa provenance, est à portée d’une requête. Une clé API est gratuite et fonctionne immédiatement.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930244425"